Clinical trials

  • MYB mRNA degrader for Adenoid cystic carcinoma
  • LEBRIKIZUMAB for Chronic rhinosinusitis with nasal polyps
  • [64Cu]Cu-PSMA-R2 for Metastatic prostate cancer|Adenocarcinoma of prostate
  • CEMIPLIMAB for Non-small cell lung cancer
  • ponatinib for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
  • NORADRENALINE TARTRATE for Ischemic stroke|Stroke
  • N-{(2S,3R)-4,4-DIFLUORO-1-(2-HYDROXY-2-METHYLPROPANOYL)-2-[(2,3',5'-TRIFLUORO[1,1'-BIPHENYL]-3-YL)METHYL]PYRROLIDIN-3-YL}ETHANESULFONAMIDE for Narcolepsy Type 1
  • IPTACOPAN for IgA nephropathy
  • BEVACIZUMAB for Ovarian cancer | Fallopian tube cancer | Peritoneal carcinoma
  • Human papillomavirus (HPV) L1 virus-like particles for types 6, 11, 16, 18, 31, 33, 45, 52, and 58 (adsorbed) for Human papillomavirus (HPV) infection | Cervical intraepithelial neoplasia (CIN) | Cervical cancer | Vulvar cancer | Vaginal cancer | Genital warts (condyloma acuminata)
  • GOZETOTIDE ALF-18 for Hepatocellular carcinoma
  • AZETUKALNER for Focal epilepsy